<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>0026-1742</journal-id>
<journal-title><![CDATA[Revista de la Facultad de Medicina (México)]]></journal-title>
<abbrev-journal-title><![CDATA[Rev. Fac. Med. (Méx.)]]></abbrev-journal-title>
<issn>0026-1742</issn>
<publisher>
<publisher-name><![CDATA[Universidad Nacional Autónoma de México, Facultad de Medicina]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S0026-17422021000500019</article-id>
<article-id pub-id-type="doi">10.22201/fm.24484865e.2021.64.5.03</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Síndrome de Stevens Johnson/necrólisis epidérmica tóxica tras ingesta de cotrimoxazol. Reporte de caso]]></article-title>
<article-title xml:lang="en"><![CDATA[Stevens Johnson syndrome/toxic epidermal necrolysis after intake of cotrimoxazole. Case report]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Vargas Álvarez]]></surname>
<given-names><![CDATA[Jesús Enrique]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Rodríguez Guzmán]]></surname>
<given-names><![CDATA[Leoncio Miguel]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Herrera Vargas]]></surname>
<given-names><![CDATA[Luis Alberto]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Universidad Veracruzana Facultad de Medicina ]]></institution>
<addr-line><![CDATA[Minatitlán Veracruz]]></addr-line>
<country>Mexico</country>
</aff>
<aff id="Af2">
<institution><![CDATA[,Instituto Mexicano del Seguro Social Hospital General de Zona No. 32 ]]></institution>
<addr-line><![CDATA[Minatitlán Veracruz]]></addr-line>
<country>Mexico</country>
</aff>
<aff id="Af3">
<institution><![CDATA[,Instituto Mexicano del Seguro Social Hospital General de Zona No. 32 ]]></institution>
<addr-line><![CDATA[Minatitlán Veracruz]]></addr-line>
<country>Mexico</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>10</month>
<year>2021</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>10</month>
<year>2021</year>
</pub-date>
<volume>64</volume>
<numero>5</numero>
<fpage>19</fpage>
<lpage>24</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_arttext&amp;pid=S0026-17422021000500019&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_abstract&amp;pid=S0026-17422021000500019&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_pdf&amp;pid=S0026-17422021000500019&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[Resumen: Las reacciones adversas a medicamentos son una emergencia, el médico de primer contacto debe de estar completamente familiarizado con ellas, debido a que pueden comprometer la función e incluso la vida de los pacientes. El síndrome de Stevens Johnson/necrólisis epidérmica tóxica, es una de las reacciones adversas más estudiadas y reportadas hasta el momento, asociándose una gran cantidad de fármacos a su aparición. Un diagnóstico temprano y un manejo adecuado del mismo, se traduce en la reducción de la mortalidad ocasionada por esta patología. Se presenta el caso de una paciente de 74 años, quien presentó este evento tras la ingesta de cotrimoxazol.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[Abstract: Adverse drug reactions are an emergency, and the first contact physician must be completely familiar with them, since they can compromise the function and even the life of patients. Stevens Johnson syndrome/toxic epidermal necrolysis is one of the most studied and reported adverse reactions to date, with a large number of drugs being associated with its appearance. An early diagnosis and an adequate management of the same results in the reduction of mortality caused by this pathology. We present the case of a 74-year-old patient who presented this event after taking cotrimoxazole.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[Síndrome de Stevens Johnson]]></kwd>
<kwd lng="es"><![CDATA[farmacodermias]]></kwd>
<kwd lng="es"><![CDATA[cotrimoxazol]]></kwd>
<kwd lng="es"><![CDATA[reacciones adversas a medicamentos]]></kwd>
<kwd lng="en"><![CDATA[Stevens Johnson syndrome]]></kwd>
<kwd lng="en"><![CDATA[pharmacoderma]]></kwd>
<kwd lng="en"><![CDATA[cotrimoxazole]]></kwd>
<kwd lng="en"><![CDATA[adverse drug reactions]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="">
<collab>Organización Mundial de la Salud</collab>
<source><![CDATA[Formulario modelo de la OMS 2004: Consejo general a los prescriptores: Efectos adversos e interacciones. Apps.who.int]]></source>
<year>2004</year>
</nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Martínez-Cabriales]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Gómez-Flores]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Ocampo-Candiani]]></surname>
<given-names><![CDATA[J.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Actualidades en farmacodermias severas: síndrome de Stevens-Johnson (SSJ) y necrólisis epidérmica tóxica (NET)]]></article-title>
<source><![CDATA[Gaceta Médica de México]]></source>
<year>2015</year>
<volume>151</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>777-87</page-range></nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="book">
<collab>Guía de práctica clínica</collab>
<source><![CDATA[Diagnóstico y tratamiento del Síndrome de Stevens Johnson/Necrolisis Epidérmica Tóxica, México]]></source>
<year>2011</year>
<publisher-name><![CDATA[Secretaría de Salud]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Auquier-Dunant]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Mockenhaupt]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Naldi]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Correia]]></surname>
<given-names><![CDATA[O]]></given-names>
</name>
<name>
<surname><![CDATA[Schroder]]></surname>
<given-names><![CDATA[W]]></given-names>
</name>
<name>
<surname><![CDATA[Roujeau]]></surname>
<given-names><![CDATA[JC.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Correlations between clinical patterns and causes of erythema Multiforme majus, Stevens-Johnson syndrome, and toxic epidermal necrolysis: results of an international prospective study]]></article-title>
<source><![CDATA[Arch Dermatol]]></source>
<year>2002</year>
<volume>138</volume>
<numero>8</numero>
<issue>8</issue>
<page-range>1019-24</page-range></nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ferreira Roviello]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Menezes Rodrigues]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Bertolini Gonçalves]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Ribeiro Nogueira Ferraz]]></surname>
<given-names><![CDATA[R.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Manifestações e tratamento da necrólise epidérmica tóxica e da síndrome de Stevens Johnson]]></article-title>
<source><![CDATA[Journal Health NPEPS]]></source>
<year>2019</year>
<volume>4</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>319-29</page-range></nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Micheletti]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Chiesa-Fuxench]]></surname>
<given-names><![CDATA[Z]]></given-names>
</name>
<name>
<surname><![CDATA[Noe]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Stephen]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Aleshin]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Agarwal]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis: A Multicenter Retrospective Study of 377 Adult Patients from the United States]]></article-title>
<source><![CDATA[Journal of Investigative Dermatology]]></source>
<year>2018</year>
<volume>138</volume>
<numero>11</numero>
<issue>11</issue>
<page-range>2315-21</page-range></nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Harr]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[French]]></surname>
<given-names><![CDATA[L.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Toxic epidermal necrolysis and Stevens-Johnson syndrome]]></article-title>
<source><![CDATA[Orphanet Journal of Rare Diseases]]></source>
<year>2010</year>
<volume>5</volume>
<numero>39</numero>
<issue>39</issue>
</nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Calvo]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Martínez-Martínez]]></surname>
<given-names><![CDATA[L.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Mecanismos de acción de los antimicrobianos]]></article-title>
<source><![CDATA[Enfermedades Infecciosas y Microbiología Clínica]]></source>
<year>2009</year>
<volume>27</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>44-52</page-range></nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Charli-Joseph]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
<name>
<surname><![CDATA[Cruz-Fuentes]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Orozco-Topete]]></surname>
<given-names><![CDATA[R.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Incidence of adverse cutaneous drug reactions in a Mexican sample: an exploratory study on their association to tumour necrosis factor alpha TNF2 allele]]></article-title>
<source><![CDATA[Journal of the European Academy of Dermatology and Venereology]]></source>
<year>2009</year>
<volume>23</volume>
<numero>7</numero>
<issue>7</issue>
<page-range>788-92</page-range></nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Hernández Salazar]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Vega Memije]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Hojyo Tomoka]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Epidemiología de las reacciones cutáneas adversas a fármacos en el Servicio de Dermatología del Hospital General Dr. Manuel Gea González]]></article-title>
<source><![CDATA[Revista Mexicana de Dermatología]]></source>
<year>2011</year>
<volume>55</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>327-33</page-range></nlm-citation>
</ref>
<ref id="B11">
<label>11</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Hsu]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Brieva]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Silverberg]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Silverberg]]></surname>
<given-names><![CDATA[J.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Morbidity and Mortality of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in United States Adults]]></article-title>
<source><![CDATA[Journal of Investigative Dermatology]]></source>
<year>2016</year>
<volume>136</volume>
<numero>7</numero>
<issue>7</issue>
<page-range>1387-97</page-range></nlm-citation>
</ref>
<ref id="B12">
<label>12</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Carrasquillo]]></surname>
<given-names><![CDATA[O]]></given-names>
</name>
<name>
<surname><![CDATA[Santiago&#8208;Vazquez]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Cardona]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Cruz&#8208;Manzano]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Figueroa]]></surname>
<given-names><![CDATA[L.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Stevens&#8208;Johnson syndrome and toxic epidermal necrolysis: a retrospective descriptive study]]></article-title>
<source><![CDATA[International Journal of Dermatology]]></source>
<year>2019</year>
<page-range>1-7</page-range></nlm-citation>
</ref>
<ref id="B13">
<label>13</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Pedigoni Bulisani]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Domingues Sanches]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Penna Guimarães]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Delascio Lopes]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Sandre Vendrame]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Carlos Lopes]]></surname>
<given-names><![CDATA[A.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Síndrome de Stevens-Johnson e Necrólise Epidérmica Tóxica em Medicina Intensiva]]></article-title>
<source><![CDATA[Revista Brasileira de Terapia Intensiva]]></source>
<year>2006</year>
<volume>18</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>292-7</page-range></nlm-citation>
</ref>
<ref id="B14">
<label>14</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Rijal]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Pompa]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Giri]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Bhatt]]></surname>
<given-names><![CDATA[V.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[A case of toxic epidermal necrolysis caused by trimethoprim-sulfamethoxazole]]></article-title>
<source><![CDATA[Case Reports]]></source>
<year>2014</year>
<volume>2014</volume>
<numero>jul09 1</numero>
<issue>jul09 1</issue>
</nlm-citation>
</ref>
<ref id="B15">
<label>15</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Sassolas]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Haddad]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Mockenhaupt]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[ALDEN, an algorithm for assessment of drug causality in Stevens-Johnson Syndrome and toxic epidermal necrolysis: comparison with case-control analysis]]></article-title>
<source><![CDATA[Clin Pharmacol Ther]]></source>
<year>2010</year>
<volume>88</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>60-8</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
